767 related articles for article (PubMed ID: 31589866)
1. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
[TBL] [Abstract][Full Text] [Related]
2. First trimester preeclampsia screening and prediction.
Chaemsaithong P; Sahota DS; Poon LC
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1071-S1097.e2. PubMed ID: 32682859
[TBL] [Abstract][Full Text] [Related]
3. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study.
Chaemsaithong P; Sahota D; Pooh RK; Zheng M; Ma R; Chaiyasit N; Koide K; Shaw SW; Seshadri S; Choolani M; Panchalee T; Yapan P; Sim WS; Sekizawa A; Hu Y; Shiozaki A; Saito S; Leung TY; Poon LC
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):206-214. PubMed ID: 31671479
[TBL] [Abstract][Full Text] [Related]
4. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
[TBL] [Abstract][Full Text] [Related]
5. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
6. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening.
Moungmaithong S; Kwan AH; Tse AW; Wong NK; Lam MS; Wang J; Poon LC; Sahota DS
PLoS One; 2023; 18(7):e0288289. PubMed ID: 37428792
[TBL] [Abstract][Full Text] [Related]
8. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
[TBL] [Abstract][Full Text] [Related]
9. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
[TBL] [Abstract][Full Text] [Related]
10. Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
Wright A; Wright D; Syngelaki A; Georgantis A; Nicolaides KH
Am J Obstet Gynecol; 2019 Feb; 220(2):197.e1-197.e11. PubMed ID: 30414394
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
[TBL] [Abstract][Full Text] [Related]
13. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
[TBL] [Abstract][Full Text] [Related]
14. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
[TBL] [Abstract][Full Text] [Related]
15. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation.
Papastefanou I; Nowacka U; Syngelaki A; Mansukhani T; Karamanis G; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2021 Nov; 225(5):530.e1-530.e19. PubMed ID: 33901487
[TBL] [Abstract][Full Text] [Related]
16. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
[TBL] [Abstract][Full Text] [Related]
18. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of second trimester prediction of preterm preeclampsia by three different screening algorithms.
Al-Amin A; Rolnik DL; Black C; White A; Stolarek C; Brennecke S; da Silva Costa F
Aust N Z J Obstet Gynaecol; 2018 Apr; 58(2):192-196. PubMed ID: 28850663
[TBL] [Abstract][Full Text] [Related]
20. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
